Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites
Overview
Affiliations
Terbah R, Testro A, Gow P, Majumdar A, Sinclair M Nutrients. 2024; 16(1).
PMID: 38201864 PMC: 10780673. DOI: 10.3390/nu16010035.
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease.
Singh V, De A, Mehtani R, Angeli P, Maiwall R, Satapathy S Hepatol Int. 2023; 17(4):792-826.
PMID: 37237088 DOI: 10.1007/s12072-023-10536-7.
Management of Portal Hypertension.
Kulkarni A, Rabiee A, Mohanty A J Clin Exp Hepatol. 2022; 12(4):1184-1199.
PMID: 35814519 PMC: 9257868. DOI: 10.1016/j.jceh.2022.03.002.
Practice guidance for the use of terlipressin for liver cirrhosis-related complications.
Qi X, Bai Z, Zhu Q, Cheng G, Chen Y, Dang X Therap Adv Gastroenterol. 2022; 15:17562848221098253.
PMID: 35601800 PMC: 9121451. DOI: 10.1177/17562848221098253.
Advances in the Management of Renal Dysfunction in Patients With Cirrhosis.
Pena Polanco N, Martin P, Carrion A Gastroenterol Hepatol (N Y). 2021; 17(5):211-220.
PMID: 34924889 PMC: 8667379.